Ohio State University Comprehensive Cancer Center
Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer
- Conditions
- Locations
- 🇺🇸
Lutheran General Cancer Care Center, Park Ridge, Illinois, United States
🇺🇸University of Chicago Cancer Research Center, Chicago, Illinois, United States
🇺🇸Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne, Indiana, United States
Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal Cancer
- Conditions
- Locations
- 🇺🇸
Central Baptist Hospital, Lexington, Kentucky, United States
🇺🇸University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
🇺🇸Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States
PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors
- Conditions
- Locations
- 🇺🇸
Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States
🇺🇸University of Chicago Cancer Research Center, Chicago, Illinois, United States
Combination Chemotherapy in Treating Patients With Solid Tumors
- Conditions
- Locations
- 🇺🇸
Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States
Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer
- Conditions
- First Posted Date
- 2003-06-06
- Last Posted Date
- 2014-02-11
- Target Recruit Count
- 25
- Registration Number
- NCT00061906
- Locations
- 🇺🇸
Ohio State University Comrehensive Cancer Center, Columbus, Ohio, United States
🇺🇸University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer
- Conditions
- Locations
- 🇺🇸
Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States
FR901228 in Treating Patients With Hematologic Cancer
- Locations
- 🇺🇸
Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States